$345.88▲ 7.86 (2.33%)
Real-time prices · US MarketsQ·Score
Buy
7.2 / 10
High-quality business with 106% return on equity and 21% profit margins.
high leverage at 6.4× debt-to-equity.
Quality
9.3
Health
4.5
Growth
8.9
Valuation
6.8
Sentiment
5.4
Analyst Target
$352.73
▲ +2.0% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
24.3×
price-to-earnings
Forward P/E
14.8×
next 12 months est.
Market Cap
$186.5B
market capitalization
Div Yield
2.98%
dividend yield
Profit Margin
21.0%
net profit margin
Gross Margin
70.8%
revenue minus COGS
ROE
106.1%
return on equity
Beta
0.47
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$261 — $391
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is AMGN a good stock to buy right now?
Based on our Q·Score of 7.2/10, Amgen Inc. is rated "Buy". High-quality business with 106% return on equity and 21% profit margins. Main risk to consider: high leverage at 6.4× debt-to-equity. This analysis is based on fundamentals, analyst consensus, and valuation data, and should not be considered financial advice.
What is the analyst price target for AMGN?
The consensus price target for AMGN is $352.73, based on the recommendations of 30 Wall Street analysts. This implies 2.0% upside from the current price of $345.88.
Is AMGN overvalued or undervalued?
Amgen Inc. (AMGN) appears fairly valued at current levels relative to analyst targets and sector peers. It trades at a 14.8× forward P/E ratio.
When does Amgen Inc. report its next earnings?
Amgen Inc. recently reported earnings. The next earnings date has not yet been announced.
What is Amgen Inc.'s profit margin?
Amgen Inc. has a net profit margin of 21.0%, which is considered high and reflects strong pricing power. Its gross margin stands at 70.8%, indicating a high-margin business model.
What is AMGN's dividend yield?
Amgen Inc. currently offers a dividend yield of 2.98%, which provides a solid income stream for dividend-focused investors. Dividend yields can change based on price movements and company payout decisions.
Is Amgen Inc.'s revenue growing?
Amgen Inc. is reporting modest revenue growth of 8.6%. Earnings are also growing at 112.1%, indicating improving profitability.
How much debt does Amgen Inc. have?
Amgen Inc. has a debt-to-equity ratio of 6.40×, reflecting a high debt-to-equity ratio, which increases financial risk especially in rising rate environments. Its current ratio is 1.14×, suggesting it should be monitored for near-term liquidity.